Home / ORCHPHARMA.NS : NSE

AI Analysis Fundamentals Valuation Video Analysis News Similar

AI Analysis

How does ORCHPHARMA.NS make money? Does ORCHPHARMA.NS have pricing power? What's the Earnings Whisper? Will ORCHPHARMA.NS profit more as the business scales? What is ORCHPHARMA.NS's management track record? Is ORCHPHARMA.NS's current price justified?

Orchid Pharma Limited

₹911.25 +$118.10 (+14.89%)

NSE · 16 Oct 2026 09:59 UTC

Previous Close

₹928.05

Day Range

₹896₹938.95

Year Range

₹480₹1143.5

Market Cap

46.22B

AVG Volume

168.66K

Trailing/Forward PE

532.89/21.49

PEG ratio

1.33

Dividend Yield

Next Earnings Date

2026-11-16

Primary Exchange

National Stock Exchange of India

Revenue (INR) · A

ORCHPHARMA.NS Revenue (INR) by year
Period	Revenue (INR)
2026	8.11B
2025	9.22B
2024	8.19B
2023	6.66B
2022	5.6B
2021	4.5B
2020	5.08B

Net Income (INR) · A

ORCHPHARMA.NS Net Income (INR) by year
Period	Net Income (INR)
2026	203.54M
2025	996.57M
2024	921.66M
2023	463.18M
2022	-19.51M
2021	-1.17B
2020	-1.31B

Operating Income (INR) · A

ORCHPHARMA.NS Operating Income (INR) by year
Period	Operating Income (INR)
2026	441.05M
2025	1.27B
2024	1.64B
2023	643.84M
2022	48.6M
2021	-479.66M
2020	-1.32B

EBITDA · A

Cash Flows · A

EPS · A

Expenses · A

Cash & Debt · A

Debt ratios · A

Margins · A

Return on Capital · A

Shares Outstanding · A

Dividends (INR) · A

Employee Count

Book Value Per Share · A

Total Assets · A

PE Ratio

Free Cash Flow Yield

Price to Sales

EV/EBITDA

Price/Operating Cashflow

Price to Book

No video analysis for this stock yet. Request one from our team.

AI Analysis

Orchid Pharma Limited

Video analysis: ORCHPHARMA.NS

News: ORCHPHARMA.NS

Similar companies